Reversible Cerebellar Leukoencephalopathy Associated With Oral Methotrexate
Journal of the Korean Neurological Association
; : 168-170, 2014.
Article
en Ko
| WPRIM
| ID: wpr-27585
Biblioteca responsable:
WPRO
ABSTRACT
Methotrexate (MTX)-induced leukoencephalopathy is the most often reported leukoencephalopathy following intrathecal or intravenous administration. A 72-year-old woman developed leukoencephalopathy localized to the cerebellum after treatment with oral MTX at a dose of 15 mg/week for 3 years. She complained of subtle imbalance during walking and reported having fallen. Her symptoms improved after discontinuation of MTX, and the leukoencephalopathy resolved. This is therefore a case report of selective cerebellar reversible leukoencephalopathy associated with oral MTX.
Palabras clave
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Cerebelo
/
Metotrexato
/
Caminata
/
Leucoencefalopatías
/
Administración Intravenosa
Límite:
Aged
/
Female
/
Humans
Idioma:
Ko
Revista:
Journal of the Korean Neurological Association
Año:
2014
Tipo del documento:
Article